Prtk stock price target
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Paratek Pharmaceuticals, Inc. (PRTK) Stock Price, Quote ... Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? Shareholders in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) had a terrible week, … PRTK:NASDAQ GM Stock Quote - Paratek Pharmaceuticals Inc ... Stock analysis for Paratek Pharmaceuticals Inc (PRTK:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Paratek Pharmaceuticals, Inc. - PRTK - Stock Price Today ... Get the latest Paratek Pharmaceuticals, Inc. PRTK detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Paratek Pharmaceuticals, Inc. - PRTK - Stock Price Today - Zacks PRTK is
Paratek Pharmaceuticals, Inc. [PRTK] Price Analysis: Next ...
Paratek Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics based upon tetracycline chemistry. Paratek Pharmaceuticals, Inc. (PRTK) Stock Price, Quote ... Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and for other public health threats for civilian, government and military use, today announced that the Biomedical Advanced Research and Development Analysts Are Bullish on Top Healthcare Stocks: Revance ... See today’s analyst top recommended stocks >> Paratek Pharmaceuticals (PRTK) In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Paratek Pharmaceuticals, with a price target of $18.00.The company’s shares closed last Monday at $3.60.
Aug 23, 2017 · Overall PRTK has a Strong Buy analyst consensus rating. In the last ten months, the stock has received 6 Buy ratings. The average analyst price target of $39.40 translates into serious upside
In depth view into PRTK (Paratek Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. PARATEK PHARMACEUTICALS, INC. : PRTK Stock Price ... Paratek Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics based upon tetracycline chemistry. Paratek Pharmaceuticals, Inc. (PRTK) Stock Price, Quote ... Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and for other public health threats for civilian, government and military use, today announced that the Biomedical Advanced Research and Development Analysts Are Bullish on Top Healthcare Stocks: Revance ...
PRTK Stock Quote - Paratek Pharmaceuticals, Inc. Common ...
Nov 06, 2019 · Their average twelve-month price target is $20.60, suggesting that the stock has a possible upside of 450.80%. The high price target for PRTK is $26.00 and the low price target for PRTK is $12.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy.". PRTK | Paratek Pharmaceuticals Inc. Analyst Estimates ... PRTK updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. PRTK Stock Price, Forecast & News (Paratek Pharmaceuticals) 7 analysts have issued 12 month target prices for Paratek Pharmaceuticals' stock. Their forecasts range from $6.00 to $36.00. On average, they expect Paratek Pharmaceuticals' stock price to reach $17.20 in the next twelve months. This suggests a possible upside of 435.8% from the stock's current price.
PRTK - Paratek Pharmaceuticals Inc Stock quote - CNNMoney.com
Paratek Pharmaceuticals, Inc. (PRTK) Surges 14.02% ... Apr 06, 2020 · The one year price forecast for PRTK stock indicates that the average analyst price target is $15 per share. This means the stock has a potential increase of 309.84% from where the PRTK share price has been trading recently. During the recent trading session for Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), the company witnessed their stock rise Stock Comparison Tool | MarketBeat
PRTK Price Target and Analyst Ratings (Paratek ...